IAA
PJP icon

Ironsides Asset Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ironsides Asset Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,786
Closed -$432K – 167
2014
Q3 		$432K Buy
6,786
+172
+3% +$10.6K 0.13% 111
2014
Q2 		$404K Buy
+6,614
New +$383K 0.12% 115

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $209M AUM 22.2% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Ironsides Asset Advisors's PJP Position: Q4 2014 in Review

Ironsides Asset Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2014, closing a stake of 6,786 shares — an estimated $432K sold.

Ironsides Asset Advisors first reported a position in PJP in Q2 2014 and held it in 2 quarters. The position peaked at $432K in Q3 2014. 97 funds tracked by Wall St. Rank hold PJP as of Q4 2014.

  • Ironsides Asset Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2014 after selling out during the quarter.
  • Ironsides Asset Advisors sold 6,786 Invesco Pharmaceuticals ETF shares in Q4 2014, an estimated $432K.
  • Ironsides Asset Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2014 and held it in 2 quarters.
  • Ironsides Asset Advisors's Invesco Pharmaceuticals ETF position peaked at $432K in Q3 2014.
  • 97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2014.

Based on Ironsides Asset Advisors's 13F filing for Q4 2014, filed 11 Feb 2015.